2019 Vince Lombardi Cancer Foundation “Leaders for a Cure” awardee
Director of Interventional Oncology and Immunotherapy, Williams Cancer Institute
First in procedures:
- Breast ablation 2003
- Combination ablation intratumoral IL2, Interferon 2005
- First in human, intratumoral 3-Bromopyruvate 2005
- First in human, combination intratumoral Yervoy/Opdivo with tumor ablation 2014
- First in human, intratumoral combination Yervoy/Opdivo/CpG/PV-10 2015
- First in human, intra-arterial infusion into liver tumors, a combination Yervoy/Opdivo 2015
- First in human, intratumoral OX40/CpG agonist 2018
Jason R. Williams is a medical doctor, board-certified radiologist, image-guided cancer specialist, researcher, and professor. He is one of the pioneers of immunotherapy, specializing in intra-tumoral interventions. He performed the world’s first ablation procedure and implemented an intra-tumoral injection of a specific combination of immunotherapy agents, thus leveraging the actual process of ablation as an immunotherapy agent itself. Since then, he has performed thousands of procedures —many of them “first in human”— in multiple areas of ablation and cryoablation therapies.